Not Yet Recruiting INTERVENTIONAL NCT07548671

Enarodustat + CsA vs CsA in Newly Diagnosed TD-NSAA

Efficacy and Safety of Enarodustat Combined With Cyclosporine Versus Cyclosporine Monotherapy in the Treatment of Newly Diagnosed TD-NSAA

Sponsor: Peking Union Medical College Hospital

Conditions Transfusion-dependent Non-severe Aplastic Anemia

Interventions Cyclosporine (CsA) Enarodustat

Updated 1 time since 2026 Last updated: Apr 16, 2026 Started: Apr 1, 2026 Primary completion: Dec 1, 2028 Completion: Dec 1, 2029

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT07548671, this observational or N/A phase trial focuses on Transfusion-dependent Non-severe Aplastic Anemia and remains actively recruiting participants. Sponsored by Peking Union Medical College Hospital, it has been updated 1 time since 2026, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

1 version recorded

Not Yet Recruiting [daily]

Eligibility Summary

This study aimed to compare the efficacy and safety of enarodustat combined with cyclosporine versus cyclosporine monotherapy in the treatment of newly-diagnosed tansfusion-dependent non-severe aplastic anemia (TD-NSAA).

Contact Information

Sponsor contact:

Peking Union Medical College Hospital

Data source: ClinicalTrials.gov

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.